LPL Financial’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.3K Sell
40,993
-2,434
-6% -$5.01K ﹤0.01% 5736
2025
Q4
$86K Buy
43,427
+1,310
+3% +$4.19K ﹤0.01% 5636
2025
Q3
$123K Buy
42,117
+23,747
+129% +$54.6K ﹤0.01% 5467
2025
Q2
$33.3K Sell
18,370
-33,983
-65% -$60.5K ﹤0.01% 5417
2025
Q1
$78.5K Buy
52,353
+5,525
+12% +$13.9K ﹤0.01% 5088
2024
Q4
$111K Sell
46,828
-32,601
-41% -$573K ﹤0.01% 4972
2024
Q3
$2.34M Buy
79,429
+17,321
+28% +$399K ﹤0.01% 2575
2024
Q2
$767K Buy
62,108
+4,397
+8% +$92.7K ﹤0.01% 3497
2024
Q1
$1.17M Buy
57,711
+1,689
+3% +$38.9K ﹤0.01% 3035
2023
Q4
$1.26M Buy
56,022
+10,825
+24% +$229K ﹤0.01% 2847
2023
Q3
$752K Buy
45,197
+623
+1% +$12.3K ﹤0.01% 3150
2023
Q2
$1.09M Sell
44,574
-7,438
-14% -$179K ﹤0.01% 2770
2023
Q1
$1.25M Buy
52,012
+9,716
+23% +$269K ﹤0.01% 2565
2022
Q4
$1.25M Buy
42,296
+2,300
+6% +$82.7K ﹤0.01% 2467
2022
Q3
$1.67M Sell
39,996
-4,021
-9% -$109K ﹤0.01% 2116
2022
Q2
$1.24M Buy
44,017
+6,984
+19% +$176K ﹤0.01% 2411
2022
Q1
$1.38M Sell
37,033
-1,682
-4% -$71.3K ﹤0.01% 2346
2021
Q4
$1.69M Buy
38,715
+18,488
+91% +$970K ﹤0.01% 2215
2021
Q3
$1.26M Buy
+20,227
New +$1.69M ﹤0.01% 2440

Other funds holding FLNA

LPL Financial's FLNA Position: Q1 2026 in Review

LPL Financial reduced its Filana Therapeutics (FLNA) stake by 5.6% in Q1 2026, selling an estimated $5.01K and leaving 40,993 shares worth $69.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5736.

LPL Financial first reported a position in FLNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.34M in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • LPL Financial held 40,993 shares of Filana Therapeutics worth $69.3K as of Q1 2026.
  • LPL Financial sold 2,434 Filana Therapeutics shares in Q1 2026, an estimated $5.01K.
  • Filana Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5736 holding.
  • LPL Financial first reported a position in Filana Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • LPL Financial's Filana Therapeutics position peaked at $2.34M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.